The latest episode of our web series with PurpleLab tackles a question regulators haven’t fully answered: what counts as health inference risk? HIPAA’s expert determination standard assesses reidentification risk against

A set of plain-English do’s and don’ts for adopting AI-enabled and agentic advertising workflows. Today, the NAI’s released new guidance, Key Do’s & Don’ts for Using AI in Network Advertising,

The healthcare marketing landscape is undergoing a massive transformation driven by advanced technologies and deidentified health data. Marketers are now leveraging Large Language Models (LLMs) with Retrieval-Augmented Generation (RAG) architectures to

Findings from More Than 70 Member Privacy Reviews Highlight Industry Progress and a Roadmap for Compliance in an Era of Accelerating State Enforcement WASHINGTON, D.C. — May 13, 2026 The

WASHINGTON, D.C. (March 3, 2026) – Today, President & CEO of the NAI, Leigh Freund issued the following statement in response to the CalPrivacy Enforcement Division’s settlement with PlayOn Sports. “Companies

[01/20/2026 – Washington, D.C.] – The NAI today announced its Board of Directors for the 2026–2027 term, welcoming five new industry experts and reappointing twelve returning members. “We are excited

On May 20, the NAI submitted comments in response to CalPrivacy’s Invitation for Preliminary Comments on Notices & Disclosures and Employee Data. In summary, the NAI recommends that CalPrivacy should:

On May 7, the NAI submitted comments in response to CalPrivacy’s Invitation for Preliminary Comments on Delete Request and Opt-Out Platform (“DROP”) Audits. The comments call on CalPrivacy to design

On April 6, 2026, the NAI (Network Advertising Initiative) submitted comments in response to CalPrivacy’s preliminary request for input on reducing friction in the exercise of privacy rights and the